K. Kuulasmaa, H. Tunstall-pedoe, and A. Dobson, Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations, The Lancet, vol.355, issue.9205, pp.675-87, 2000.
DOI : 10.1016/S0140-6736(99)11180-2

K. Kotseva, D. Wood, D. Backer, G. , D. Bacquer et al., Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, The Lancet, vol.373, issue.9667, pp.929-969, 2009.
DOI : 10.1016/S0140-6736(09)60330-5

B. Unal, J. Critchley, and S. Capewell, Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention, BMJ, vol.331, issue.7517, p.614, 2005.
DOI : 10.1136/bmj.38561.633345.8F

C. Berg, L. Lissner, and N. Aires, Trends in blood lipid levels, blood pressure, alcohol and smoking habits from, Eur J Cardiovasc Prev Rehabil, vol.12, pp.115-140, 1985.

J. Ferrieres, V. Bongard, and J. Dallongeville, Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996???2007, Archives of Cardiovascular Diseases, vol.102, issue.4, pp.293-301, 1996.
DOI : 10.1016/j.acvd.2009.02.002

L. Serra-majem, M. Pastor-ferrer, and C. Castell, Trends in blood lipids and fat soluble vitamins in Catalonia, Public Health Nutr, vol.10, pp.1379-88, 1992.

M. Grau, I. Subirana, and R. Elosua, Trends in cardiovascular risk factor prevalence (1995???2000???2005) in northeastern Spain, European Journal of Cardiovascular Prevention & Rehabilitation, vol.19, issue.5, pp.653-662, 1995.
DOI : 10.1097/HJR.0b013e3281764429

M. Li, K. Ong, H. Tse, and B. Cheung, Utilization of lipid lowering medications among adults in the United States 1999???2006, Atherosclerosis, vol.208, issue.2, pp.456-60, 2010.
DOI : 10.1016/j.atherosclerosis.2009.08.001

M. Carroll, D. Lacher, and P. Sorlie, Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002, JAMA, vol.294, issue.14, pp.1773-81, 1960.
DOI : 10.1001/jama.294.14.1773

D. Arnett, D. Jacobs, J. Luepker, R. Blackburn, H. Armstrong et al., Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use: The Minnesota Heart Survey, 1980-1982 to 2000-2002, Circulation, vol.112, issue.25, pp.3884-91, 1980.
DOI : 10.1161/CIRCULATIONAHA.105.549857

E. Kuklina, P. Yoon, and N. Keenan, Trends in High Levels of Low-Density Lipoprotein Cholesterol in the United States, 1999-2006, JAMA, vol.302, issue.19, pp.2104-2114, 1999.
DOI : 10.1001/jama.2009.1672

C. Neutel, H. Morrison, N. Campbell, and G. De, Statin use in Canadians: trends, determinants and persistence, Can J Public Health, vol.98, pp.412-418, 2007.

M. Hobbs, M. Knuiman, T. Briffa, H. Ngo, and K. Jamrozik, Plasma cholesterol levels continue to decline despite the rising prevalence of obesity: population trends in Perth, Western Australia, 1980???1999, European Journal of Cardiovascular Prevention & Rehabilitation, vol.29, issue.1, pp.319-343, 1980.
DOI : 10.1097/HJR.0b013e3282f3c76b

P. Metcalf, R. Scragg, B. Swinburn, and L. Shaw, Factors associated with changes in serum total cholesterol levels over 7 years in middle-aged New Zealand men and women: a prospective study, Nutr Metab Cardiovasc Dis, vol.11, pp.298-305, 2001.

I. Graham, D. Atar, and K. Borch-johnsen, Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts), European Journal of Cardiovascular Prevention & Rehabilitation, vol.14, issue.2_suppl, pp.1-113, 2007.
DOI : 10.1097/01.hjr.0000277983.23934.c9

R. Scranton, H. Sesso, M. Stampfer, J. Levenson, J. Buring et al., Predictors of 14-year changes in the total cholesterol to high-density lipoprotein cholesterol ratio in men, American Heart Journal, vol.147, issue.6
DOI : 10.1016/j.ahj.2003.11.018

E. Ingelsson, J. Massaro, and P. Sutherland, Contemporary Trends in Dyslipidemia in the Framingham Heart Study, Archives of Internal Medicine, vol.169, issue.3, pp.279-86, 2009.
DOI : 10.1001/archinternmed.2008.561

Y. Cui, D. Watson, and C. Girman, Effects of Increasing High-Density Lipoprotein Cholesterol and Decreasing Low-Density Lipoprotein Cholesterol on the Incidence of First Acute Coronary Events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study), The American Journal of Cardiology, vol.104, issue.6, pp.829-863, 2009.
DOI : 10.1016/j.amjcard.2009.05.020

H. Nakamura, K. Arakawa, and H. Itakura, Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial, The Lancet, vol.368, issue.9542, pp.1155-63, 2006.
DOI : 10.1016/S0140-6736(06)69472-5

E. Brunner, K. Rees, K. Ward, M. Bruke, and M. Thorogood, Dietary advice for reducing cardiovascular risk, Cochrane Database of Systematic Reviews, 2007.

B. Howard, H. Van, and J. Hsia, Low-Fat Dietary Pattern and Risk of Cardiovascular Disease, JAMA, vol.295, issue.6
DOI : 10.1001/jama.295.6.655

K. Varady and P. Jones, Combination diet and exercise interventions for the treatment of dyslipidemia: an effective preliminary strategy to lower cholesterol levels?, J Nutr, vol.135, pp.1829-1864, 2005.

. Non-white, 27) -1.00 (1.13) Reference

. Pufas, SFAs Increase (?1 SD) -1.69 (-1.80 to -1.57), pp.0-001